- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Patients With Advanced Solid Tumor or Lymphoma
Total 2870 results
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownPatients With Advanced or Metastatic Solid TumorsFrance
-
Disphar International B.V.CompletedPatients With Advanced or Metastatic Solid Tumors
-
Suzhou Genhouse Bio Co., Ltd.Not yet recruitingPatient With Advanced Solid TumorChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingPatients With Advanced Solid TumorsChina
-
Beijing InnoCare Pharma Tech Co., Ltd.Not yet recruitingPatients With Advanced Solid TumorsChina
-
Bio-Thera SolutionsGeorge Clinical Pty LtdActive, not recruiting
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingPatients With Advanced Solid TumorsChina
-
Gustave Roussy, Cancer Campus, Grand ParisRecruiting
-
Beijing Tide Pharmaceutical Co., LtdRecruitingPatients With Advanced Solid TumorsChina
-
PharmaMarRecruitingPatients With Advanced Solid TumorsSpain
-
Tianjin Hemay Oncology Pharmaceutical Co., LtdRecruitingPatients With Advanced Stage Solid TumorsChina
-
Ascentage Pharma Group Inc.CompletedPatients With Advanced Solid Tumor or LymphomaUnited States
-
IconOVir BioRecruitingPatients With Advanced Solid TumorsUnited States
-
Nektar TherapeuticsCompletedAdvanced or Metastatic Solid Tumors in Patients With Hepatic ImpairmentUnited States
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
Elevar TherapeuticsBukwang Pharmaceutical, Co., Ltd.CompletedCancer Patients With Solid TumorsKorea, Republic of, United States
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, United States, Taiwan, Singapore, France
-
Brugmann University HospitalCompletedElderly Patients With a Solid TumorBelgium
-
Memorial Sloan Kettering Cancer CenterCompletedPediatric Patients With Solid TumorsUnited States
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
Jiangsu Simcere Pharmaceutical Co., Ltd.RecruitingAdvanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene FusionChina
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingPatients With Advanced Malignant TumorsChina
-
Assistance Publique - Hôpitaux de ParisCompletedPatients With Advanced Lymphoid Malignancies in the Absence of an HLA Identical or Mismatch DonorFrance
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Solid Tumor or Hematologic TumorChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced Solid Tumor or Hematologic TumorChina
-
Shanghai Changzheng HospitalNot yet recruitingAdvanced Solid Tumors With Neuroendocrine Differentiation
-
Sichuan Kelun Pharmaceutical Research Institute...RecruitingSelected Subjects With Advanced Solid TumorsChina
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedPatients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is AvailableUnited States
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
D3 Bio (Wuxi) Co., LtdRecruitingAdvanced Solid Tumors With MAPK Pathway MutationsAustralia, China, United States
-
Beijing Mabworks Biotech Co., Ltd.RecruitingAdvanced or Metastatic Solid TumorChina
-
Zai Lab (Shanghai) Co., Ltd.Mirati Therapeutics Inc.Active, not recruitingAdvanced or Metastatic Solid TumorChina
-
BayerCompletedAdvanced or Metastatic Solid TumorUnited States, Spain, Korea, Republic of, Belgium, Singapore, Germany
-
Lantern Pharma Inc.RecruitingAdvanced Solid Tumor | Relapsed or Refractory LymphomasUnited States
-
Suzhou Genhouse Bio Co., Ltd.Shanghai East Hospital; Shandong Tumor HospitalRecruitingAdvanced Solid Tumors With MAPK Signal Pathway MutantChina
-
Suzhou Kebo Ruijun Biotechnology Co., LtdRecruitingAdvanced Solid Tumors or LymphomasChina
-
Hunan Province Tumor HospitalRecruitingAdvanced Solid Tumors or LymphomasChina
-
Novita Pharmaceuticals, Inc.RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
GigaGen, Inc.National Cancer Institute (NCI)RecruitingAdvanced or Metastatic Solid Tumor MalignanciesUnited States
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingAdvanced Or Metastatic Solid Tumor MalignanciesChina
-
BeiGeneCompletedFor Participants With Advanced Solid Tumors Failed With Previous Lines of TreatmentAustralia
-
Suzhou Kanova Biopharmaceutical Co., LTDNot yet recruitingAdvanced or Metastatic Solid Tumors
-
Parthenon Therapeutics, Inc.RecruitingAdvanced or Metastatic Solid TumorsUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingPatients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to RadiationCanada